1. Medtech Insight
  2. >>Geography
  3. >>Europe

Angiodynamics Initiates Thrombectomy Trial In Europe After Showing Positive Trial Results in US

 
• By Marion Webb

According to Zacks Equity Research, the new trial seeks to support AlphaVac’s adoption in the European market, where pulmonary embolism prevalence and severity is an estimated 435,000 events annually.

Pulmonary Embolism
• Source: Shutterstock

AngioDynamics, Inc. has initiated the RECOVER-AV clinical trial of its AlphaVac Multipurpose Mechanical Aspiration F1885 system for treating intermediate-risk pulmonary embolism in Europe, following the success of the US-based APEX-AV trial.

The Latham, NY-based medical device company announced on 19 September the launch of the prospective, multicenter, multi-national, single-arm trial evaluating the efficacy, safety and long-term functional outcomes of percutaneous mechanical aspiration thrombectomy for treating acute pulmonary

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Health Secretary Defends Spending Cuts During Senate Hearing On HHS Budget

 
• By Elizabeth Orr

Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 
• By Brian Bossetta

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.

Califf Warns Progress May Be In Danger Due To ‘Decimated’ FDA Staff

 
• By Barnaby Pickering

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.